Board Meeting17 Aug 2026, 06:10 pm
Aptus Pharma Approves Preferential Issue of 16.03 Lakh Shares
AI Summary
Aptus Pharma Ltd announced the outcome of its Board Meeting held on August 17, 2026. The board approved a preferential issue of 16,02,870 equity shares of face value ₹10 each at an issue price of ₹280 per share, aggregating to approximately ₹44.88 Crores. The meeting also took on record the valuation report, certificates from the Practicing Company Secretary and Statutory Auditor confirming compliance with SEBI ICDR Regulations and the Companies Act, 2013. Additionally, the board approved the convening of the 16th Annual General Meeting on September 14, 2026, to be held through Video Conferencing/Other Audio-Visual Means.
Key Highlights
- Board approved preferential issue of 16,02,870 equity shares.
- Issue price fixed at ₹280 per share, raising approx. ₹44.88 Crores.
- Final number of allottees and shares approved.
- AGM scheduled for September 14, 2026, via VC/AVM.
- Compliance certificates from PCS and Statutory Auditor taken on record.
Price Impact
More from APPL